At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 2,628 enrolled
Drug / intervention
Zincdrug
Likely dose
Zinc 10 mg elemental zinc daily for infants, 20 mg daily for children 12–35 monthsAI-extracted
Key inclusion· 3
- ✓Child presenting with cough or difficult breathing and elevated respiratory rate (pneumonia)
- ✓Child presenting with cough or difficult breathing and chest indrawing, without danger signs (severe pneumonia)
- ✓Must be able to take Zinc
Key exclusion· 8
- ✕Requires special care for severe illness other than pneumonia
- ✕Severe malnutrition defined as <70% NCHS median weight for height
- ✕Presence of congenital heart disease
- ✕Documented tuberculosis
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Community- and Health Facility-based Intervention With Zinc as Adjuvant Therapy for Pneumonia to Enhance Child Health and Nutrition
In Brief
A Phase 3 clinical trial evaluating Zinc for Pneumonia. Completed, enrolled 2,628 participants across 1 site.
Detailed Summary
The aim of the study described is to measure the degree with which zinc given as adjunct therapy to standard antibiotic treatment during childhood pneumonia reduces the risk of treatment failure and the duration of the illness.
Study Details
Timeline
Phase 3CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2004
First PostedSep 2005
Primary CompletionJan 2008
TodayJul 2026
First PostedSep 8, 2005
Enrollment StartJan 1, 2004
Primary CompletionJan 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 20.8 years ago
Interventions
Zincdrug
Dissolvable zinc tablet 10 mg elemental zinc per day for infants 20 mg elemental zinc per day for children 12 to 35 months